If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrk Us Inc Etf Regulatory News (INCE)

Share Price Information for Frk Us Inc Etf (INCE)

Share Price is delayed by 15 minutes
Get Live Data
9.943    -0.005 (-0.05%)
Bid:
9.904
Ask:
9.944
Spread: 0.04 (0.404%)
Market Cap: -
INCE Live PriceLast checked at - London Stock Exchange

Intraday Frk Us Inc Etf Share Chart

Close of Accelerated Bookbuild

24 Jan 2019 10:44

RNS Number : 0224O
Gordon Dadds Group PLC
24 January 2019
 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN GORDON DADDS GROUP PLC OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH, ANY INVESTMENT DECISION IN RESPECT OF GORDON DADDS GROUP PLC.

This Announcement does not constitute a prospectus or offering memorandum or an offer in respect of any securities and is not intended to provide the basis for any investment decision in respect of Gordon Dadds or other evaluation of any securities of Gordon Dadds or any other entity and should not be considered as a recommendation that any investor should subscribe for or purchase any such securities.

 

This Announcement contains inside information for the purposes of the market abuse regulation (EU No. 596/2014) ("MAR"). Upon the publication of this Announcement, this inside information is now considered to be in the public domain.

 

Capitalised terms in this Announcement shall have the meanings given to such terms in the Company's announcement this morning.

 

 

24 January 2019

Gordon Dadds Group plc

("Gordon Dadds" or the "Company")

 

Close of Accelerated Bookbuild

 

The Company is pleased to announce that further to the announcement made earlier today, the bookbuild has been successful and is well oversubscribed so is now closed. Participants in the Placing will be contacted by Arden to confirm their allocations. A further announcement will be made in due course confirming the details of the Placing.

 

The issue of the Placing Shares is conditional, amongst other things, on the passing of the Placing Resolutions at the General Meeting and the admission of the Placing Shares to trading on AIM.

 

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 

Gordon Dadds Group plc

Adrian Biles, Chief Executive Officer

Christopher Yates, Chief Financial Officer

Via Portland

Arden Partners plc

Nominated Adviser and sole broker to the Company

 

John Llewellyn-Lloyd / Ciaran Walsh / Alex Penney - Corporate Finance

Fraser Marshall - Head of Equities

 

+44 (0) 20 7614 5900

 

Portland Communications

Steffan Williams

Simon Hamer

 

+44 (0) 20 7554 1789

Email: gordondadds@portland-communications.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEPGUGCGUPBGUC
Date   Source Headline
15th May 20237:00 amRNSCancellation - INCE GROUP PLC (THE)
28th Apr 20234:20 pmRNSAppointment of administrator and sale of business
13th Apr 20235:45 pmRNSInce Group
13th Apr 20237:00 amRNSResignation of Nominated Adviser and Broker
12th Apr 20232:30 pmRNSIntention to appoint administrator
3rd Apr 20237:00 amRNSChange of Broker
31st Mar 20234:17 pmRNSCompletion of strategic disposals
14th Mar 20232:36 pmRNSUpdate on Financial Results
27th Feb 20237:00 amRNSUpdate on Financial Results
20th Feb 202310:49 amRNSDirector shareholding
10th Feb 20239:16 amRNSReplacement: Update on Financial Results
10th Feb 20237:00 amRNSUpdate on Financial Results
31st Jan 20237:00 amRNSUpdate on Financial Results
27th Jan 20239:54 amRNSStrategic Disposal of Non-Core Practice
16th Jan 20237:00 amRNSCompletion of Arden Partners disposal
12th Jan 20237:00 amRNSArden Partners Disposal Update
3rd Jan 20237:30 amRNSSuspension - The Ince Group plc
3rd Jan 20237:00 amRNSArden Partners disposal - FCA approval received
28th Dec 20225:42 pmRNSHolding(s) in Company
22nd Dec 20225:25 pmRNSUpdate on Financial Results - Suspension of Shares
6th Dec 20224:45 pmRNSHolding in Company
2nd Dec 202211:12 amRNSHolding(s) in Company
1st Dec 20225:56 pmRNSHolding(s) in Company
1st Dec 20225:27 pmRNSHolding(s) in Company
30th Nov 20225:00 pmRNSTotal Voting Rights
24th Nov 20227:00 amRNSResult of Placing and REX Retail Offer and TVR
23rd Nov 20224:58 pmRNSREX Retail Offer for up to £0.25 million
23rd Nov 20224:55 pmRNSProposed Placing, Retail offer and Trading Update
16th Nov 20227:00 amRNSConditional disposal of Arden Partners plc
9th Nov 20227:00 amRNSBoard Appointment
7th Nov 20223:06 pmRNSHolding(s) in Company
7th Nov 20227:00 amRNSHolding(s) in Company
31st Oct 20225:00 pmRNSTotal Voting Rights
17th Oct 202210:56 amRNSEmployee subscription, director holding & TVR
14th Oct 20221:27 pmRNSHolding(s) in Company
13th Oct 20221:38 pmRNSHolding(s) in Company
11th Oct 20227:00 amRNSCost rationalisation programme update
7th Oct 20227:00 amRNSSubscription for shares, holding in Company & TVR
4th Oct 202211:21 amRNSHolding(s) in Company
3rd Oct 20227:00 amRNSProposed disposal of Gibraltar subsidiaries
30th Sep 20225:00 pmRNSTotal Voting Rights
30th Sep 202212:19 pmRNSResult of AGM
30th Sep 20227:00 amRNSTrading Update
28th Sep 20227:00 amRNSRelated party transaction
15th Sep 20227:00 amRNSDisposal of CW Energy LLP
12th Sep 20227:00 amRNSBoard and Senior Management Change
8th Sep 202211:02 amRNSTR-1
7th Sep 202212:34 pmRNSTR-1
6th Sep 20225:05 pmRNSNotice of AGM and Annual Report & Accounts update
1st Sep 20227:00 amRNSSubscription for shares and total voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.